TEK and neoplasm: Although the precise mechanism by which TIE-2 intracellular pathway mediates IFN-γ production by T cells is not yet elucidated, we demonstrated that this involved an active TIE-2 signaling, since the use of TIE-2 kinase-specific inhibitors restored this ability of tumor-specific T-cells.